Moderna pushes forward with phase 3 study

Question

Right now, the overarching strategy behind developing a Covid-19 vaccine calls for getting the work done fast. And Moderna’s team is flooring their program into a Phase III pivotal in a matter of weeks after selecting the dose needed.

The messenger RNA biotech reported this morning that it is advancing its coronavirus vaccine — mRNA-1273 — into a pivotal Phase III with 30,000 participants starting in July, just weeks away. With feedback from the FDA,

nature1970 · Answer

Right now, the overarching strategy behind developing a Covid-19 vaccine calls for getting the work done fast. And Moderna’s team is flooring their program into a Phase III pivotal in a matter of weeks after selecting the dose needed.

The messenger RNA biotech reported this morning that it is advancing its coronavirus vaccine — mRNA-1273 — into a pivotal Phase III with 30,000 participants starting in July, just weeks away. With feedback from the FDA,

nature1970 · Answer

The dosage is set at 100ug. God speed.

wallstreetcappers · Answer

How many in this trial, 20?

nature1970 · Answer

30000 but it is delayed till the end of the month.

Moderna pushes forward with phase 3 study

Hot Forum Topics